弥合差距:从通用生殖基因检测指南到胰腺癌护理中的现实世界实施
Harshabad Singh1,2,3, Ryan D Nipp4
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
JCO oncology practice
|May 8, 2024
概括
胰腺腺癌的普遍生殖线检测至关重要. 这篇编辑文章解决了不充分的测试率,并提出了需要合作的解决方案,以改善患者护理.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 医学研究 医学研究
背景情况:
- 胰腺腺癌的管理正在发展.
- 细菌线检测可以识别遗传性癌症风险.
- 目前的胰腺癌生殖基因检测率不足.
研究的目的:
- 审查支持胰腺腺癌普遍生殖基因检测的证据.
- 为了确定足够的生殖线检测率的障碍.
- 提出改善生殖线检测普及的解决方案.
主要方法:
- 对胰腺癌生殖基因检测现有数据的审查.
- 分析导致低测试率的因素.
- 讨论提高测试可访问性的策略.
主要成果:
- 数据支持普遍生殖系检测的好处.
- 几个因素阻碍了广泛实施.
- 跨学科的合作对于改进至关重要.
结论:
- 全球生殖基因检测应该是胰腺腺癌的标准.
- 解决不充分的测试需要创新的,协作的方法.
- 改进的测试将提高患者的治疗结果和家庭风险评估.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...